18F-PF-06445974 | m-entrepreneurship.com

Product Name :
18F-PF-06445974

Search keywords :
PDE4B

drugId :
null

Target Vo:
Phosphodiesterase 4B

Target Vo Short Name :
PDE4B

Moa_Name:
Phosphodiesterase 4B inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
National Institute Of Mental Health (Nimh)

Active Indication_Name:
Depression

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
COX IV Rabbit mAb In Vivo
Acetyl-Histone H3 (Lys27) Rabbit mAb Technical Information
Ku70 Antibody (YA319): Ku70 Antibody (YA319) is a non-conjugated and Rabbit origined monoclonal antibody about 70 kDa, targeting to Ku70. It can be used for WB,IHC-F,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts